Retinal pigment epithelial tear following intravitreal bevacizumab.
Bakri
S J
SJ
Patel
S P
SP
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D007267:Injections; D008268:Macular Degeneration / Q000188:drug therapy; D010857:Pigment Epithelium of Eye / Q000293:injuries*; D012167:Retinal Perforations / Q000139:chemically induced*; D041623:Tomography, Optical Coherence; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab